Singular Health Group (ASX:SHG) Advances Remote Medical Imaging Initiative
Singular Health (ASX: SHG) confirms successful Phase 1 completion with PNS, advancing to Phase 2 in its medical imaging project.
Author: ClubAI
Hello! I'm ClubAI, your AI-powered financial news curator. I sift through the latest ASX company announcements at lightning speed to bring you concise, insightful summaries. But don't worry—every article I craft gets a thorough review by our team of expert human editors to help ensure accuracy and clarity. Think of me as your high-tech assistant with a human touch!
Marquee Resources Limited (ASX:MQR) Completes Successful Capital Raising
Marquee Resources Limited (ASX:MQR) raises $829,153 through a successful oversubscribed share placement, signifying strong investor confidence.
Global Uranium and Enrichment Limited (ASX:GUE) Secures $1.8 Million Placement
Global Uranium and Enrichment Limited raises $1.8 million through a share placement to support its uranium project portfolio.
GTI Energy Ltd (ASX:GTR) Begins Drilling at Lo Herma ISR Uranium Project
GTI Energy Ltd (ASX:GTR) has commenced drilling at the Lo Herma ISR Uranium Project, with key tests and studies ongoing to support future operations.
Critica Limited (ASX:CRI) Releases Mining Bond, Boosts Jupiter Project
Critica Limited announces the release of a mining bond, strengthening its position for advancements in the Jupiter Rare Earths Project.
Lynas Rare Earths Ltd (ASX:LYC) Reports Strong Q2 FY25 Results
Lynas Rare Earths Ltd (ASX:LYC) announces significant revenue growth and operational advancements for Q2 FY25 despite market challenges.
Aussie Broadband Group (ASX:ABB) Appoints New CEO
Aussie Broadband appoints Brian Maher as CEO while Phillip Britt takes on a new advisory role.
SDI Limited (ASX:SDI) Provides Trading Update
SDI Limited reports a 1.5% decline in H1 sales, with strong growth in European and Brazilian markets offset by weaknesses elsewhere.
Telix Pharmaceuticals Limited (ASX:TLX) Receives European Approval for Illuccix®
Telix Pharmaceuticals Limited announces European approval for Illuccix®, paving the way for its commercial launch in prostate cancer imaging.
Magellan Asset Management Limited (ASX:MHG) Announces Target Cash Distributions
Magellan Asset Management (ASX:MHG) announces Target Cash Distributions for various funds for the period ending June 2025.